Historical Stock Price
ETFs Holding ADMS »    ADMS Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
02/13/2017 $16.93 $16.93 $16.51 $16.64 85.50K
02/14/2017 $16.62 $17.12 $16.52 $17.07 90.40K
02/15/2017 $17.12 $17.35 $16.75 $17.21 104.60K
02/16/2017 $17.24 $17.36 $16.60 $17.09 115.70K
02/17/2017 $17.11 $17.77 $16.98 $17.28 72.70K
Adamas Pharmaceuticals is a pharmaceutical company focused on the development and commercialization of therapeutics targeting chronic disorders of the central nervous system. Co. is developing its wholly-owned product candidate, ADS-5102, for multiple indications including a complication associated with the treatment of Parkinson's disease known as levodopa-induced dyskinesia, and ADS-4101 compound for the treatment of epilepsy. Co.'s other product candidates include ADS-8704 for the treatment of moderate to severe dementia related to Alzheimer's disease. Co.'s portfolio also includes Namzaric™ and Namenda XR® extended release capsules for indications relating to Alzheimer's disease.
ADMS historical stock prices picture
Adamas Pharmaceuticals (ADMS) has the following price history information. Looking back at ADMS historical stock prices for the last five trading days, on February 13, 2017, ADMS opened at $16.93, traded as high as $16.93 and as low as $16.51, and closed at $16.64. Trading volume was a total of 85.50K shares. On February 14, 2017, ADMS opened at $16.62, traded as high as $17.12 and as low as $16.52, and closed at $17.07. Trading volume was a total of 90.40K shares. On February 15, 2017, ADMS opened at $17.12, traded as high as $17.35 and as low as $16.75, and closed at $17.21. Trading volume was a total of 104.60K shares. On February 16, 2017, ADMS opened at $17.24, traded as high as $17.36 and as low as $16.60, and closed at $17.09. Trading volume was a total of 115.70K shares. On February 17, 2017, ADMS opened at $17.11, traded as high as $17.77 and as low as $16.98, and closed at $17.28. Trading volume was a total of 72.70K shares.

ADMS Historical Stock Prices By Date:

ADMS historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Adamas Pharmaceuticals shares, starting with a $10,000 purchase of ADMS, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/10/2014
End date: 02/17/2017
Start price/share: $14.01
End price/share: $17.28
Dividends collected/share: $0.00
Total return: 23.34%
Average Annual Total Return: 7.61%
Starting investment: $10,000.00
Ending investment: $12,334.09
Years: 2.86
Date Close
02/13/2017$16.64
02/14/2017$17.07
02/15/2017$17.21
02/16/2017$17.09
02/17/2017$17.28
ADMS is categorized under the Healthcare sector; below are some other companies in the same sector:

ADPT Historical Stock Prices
ADRO Historical Stock Prices
ADUS Historical Stock Prices
ADVM Historical Stock Prices
ADXS Historical Stock Prices
AEGR Historical Stock Prices
AEMD Historical Stock Prices
AERI Historical Stock Prices
AEZS Historical Stock Prices
AFAM Historical Stock Prices

ADMS Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2017, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.